Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-16-156547)

Filing Details

Accession Number:: 0001209191-16-156547
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-12-22 16:50:16
Reporting Period:: 2016-12-20

Filing Date:: 2016-12-22
Accepted Time:: 2016-12-22 16:50:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1510580	Kite Pharma Inc.	KITE	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1611024	D David Chang	C/O Kite Pharma, Inc. 2225 Colorado Avenue Santa Monica CA 90404	Evp, R&D, Chief Medical Off.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-12-20	1,788	$50.86	25,123	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Shares were sold to cover the tax obligation that occurred upon the vesting of an RSU.
Includes 821 shares acquired under the 2014 Employee Stock Purchase Plan (the "ESPP") on February 19, 2016 and 686 shares acquired under the ESPP on August 19, 2016.